Searched for: subject:"Breath%5C+Tests"
(1 - 3 of 3)
document
Pasman, W. (author), Wils, D. (author), Saniez, M.H. (author), Kardinaal, A. (author), TNO Kwaliteit van Leven TNO Voeding (author)
Objective: To determine the gastrointestinal (GI) tolerance of NUTRIOSE®FB in men. Design: A randomized, placebo-contro lled, parallel, double-blind study. Setting: The metabolic ward of TNO Quality of Life. Subjects: Forty-eight subjects started the study: 16 men participated in one of the three treatments. Subjects consumed either 22.5 g of...
article 2006
document
Reichl, F.X. (author), Durner, J. (author), Kunzelmann, K.H. (author), Hickel, R. (author), Spahl, W. (author), Hume, W.R. (author), Moes, G.W.H (author), Kehe, K. (author), Walther, U. (author), Forth, W. (author)
The excretion of the dental composite component triethylene glycol dimethacrylate (TEGDMA) in feces and urine in vivo and, using the pendular perfusion technique with segments of jejunum and colon, the biliary and enteric excretion in situ were investigated in anesthetized guinea pigs. In the in situ experiments guinea pigs (n=4) received TEGDMA...
article 2001
document
de Bie, A.T.H.J. (author), van Ommen, B. (author), Bär, A. (author), Centraal Instituut voor Voedingsonderzoek TNO (author)
The absorption, disposition, metabolism, and excretion of 14C-labeled γ-cyclodextrin ([14C]γ-CD) was examined in four separate experiments with Wistar rats. In experiment 1, [14C]γ-CD (25 μCi, 600 mg/kg body wt) was administered intravenously to four male and four female conventional rats. In experiment 2, [14C]γ- CD (25 μCi, 1000 mg/kg body wt)...
article 1998